$19.35
0.040.21%
At close: -
$19.35
0.000.00%
After Hours: May 2, 4:00 PM EDT
Comments
Loading...
Castle Biosciences Earnings Estimates, EPS & Revenue | NASDAQ:CSTL | Benzinga
Castle Biosciences reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 5
EPS
–
Quarterly Revenue
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$332.07M
Analyze the earnings history of Castle Biosciences using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CSTL | Castle Biosciences | $0.31 | — | — | — | $87.00M | — | — | — | 08/04/2025 | Get Alert |
| CSTL | Castle Biosciences | -$0.09 | -$0.07 | — | — | $72.97M | $80.40M | — | — | 05/05/2025 | Get Alert |
| CSTL | Castle Biosciences | -$0.10 | $0.04 | $0.32 | 700.00% | $66.12M | $83.89M | $86.31M | 2.89% | 02/27/2025 | Get Alert |
| CSTL | Castle Biosciences | -$0.26 | -$0.06 | $0.08 | 233.33% | $61.49M | $79.84M | $85.78M | 7.44% | 11/04/2024 | Get Alert |
| CSTL | Castle Biosciences | -$0.70 | -$0.29 | $0.31 | 206.90% | $50.14M | $69.08M | $87.00M | 25.94% | 08/05/2024 | Get Alert |
| CSTL | Castle Biosciences | -$1.10 | -$0.33 | -$0.09 | 72.73% | $42.04M | $66.20M | $72.97M | 10.23% | 05/02/2024 | Get Alert |
| CSTL | Castle Biosciences | -$0.78 | -$0.54 | -$0.10 | 81.48% | $38.34M | $56.28M | $66.12M | 17.48% | 02/28/2024 | Get Alert |
| CSTL | Castle Biosciences | -$0.77 | -$0.76 | -$0.26 | 65.79% | $37.01M | $48.52M | $61.49M | 26.74% | 11/02/2023 | Get Alert |
| CSTL | Castle Biosciences | -$0.77 | -$1.01 | -$0.70 | 30.69% | $34.84M | $43.51M | $50.14M | 15.23% | 08/02/2023 | Get Alert |
| CSTL | Castle Biosciences | -$0.97 | -$0.89 | -$1.10 | -23.60% | $26.85M | $37.37M | $42.04M | 12.49% | 05/03/2023 | Get Alert |
| CSTL | Castle Biosciences | -$0.25 | -$0.84 | -$0.78 | 7.14% | $25.04M | $37.16M | $38.34M | 3.17% | 02/28/2023 | Get Alert |
| CSTL | Castle Biosciences | -$0.44 | -$0.88 | -$0.77 | 12.50% | $23.48M | $34.75M | $37.01M | 6.51% | 11/02/2022 | Get Alert |
| CSTL | Castle Biosciences | -$0.35 | -$0.76 | -$0.77 | -1.32% | $22.76M | $28.37M | $34.84M | 22.80% | 08/08/2022 | Get Alert |
| CSTL | Castle Biosciences | -$0.17 | -$0.71 | -$0.97 | -36.62% | $22.81M | $25.21M | $26.85M | 6.51% | 05/09/2022 | Get Alert |
| CSTL | Castle Biosciences | -$0.17 | -$0.47 | -$0.25 | 46.81% | $17.30M | $23.74M | $25.04M | 5.47% | 02/28/2022 | Get Alert |
| CSTL | Castle Biosciences | -$0.23 | -$0.40 | -$0.47 | -17.50% | $15.22M | $22.97M | $23.48M | 2.20% | 11/08/2021 | Get Alert |
| CSTL | Castle Biosciences | -$0.08 | -$0.37 | -$0.34 | 8.11% | $12.71M | $18.93M | $22.76M | 20.22% | 08/09/2021 | Get Alert |
| CSTL | Castle Biosciences | $0.03 | -$0.24 | -$0.17 | 29.17% | $17.42M | $16.66M | $22.81M | 36.93% | 05/10/2021 | Get Alert |
| CSTL | Castle Biosciences | $0.11 | -$0.12 | -$0.17 | -41.67% | $17.64M | $15.74M | $17.30M | 9.90% | 03/08/2021 | Get Alert |
| CSTL | Castle Biosciences | $0.02 | -$0.11 | -$0.23 | -109.09% | $14.78M | $14.99M | $15.22M | 1.51% | 11/09/2020 | Get Alert |
| CSTL | Castle Biosciences | -$1.05 | -$0.40 | -$0.08 | 80.00% | $10.74M | — | $12.71M | — | 08/10/2020 | Get Alert |
| CSTL | Castle Biosciences | — | -$0.15 | $0.03 | 120.00% | — | $13.79M | $17.42M | 26.31% | 05/11/2020 | Get Alert |
Castle Biosciences (CSTL) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $0.32 | $0.04 | 700.0 % |
| Q3 | 2024-11-04 | $0.08 | $-0.06 | 233.3 % |
| Q2 | 2024-08-05 | $0.31 | $-0.29 | 206.9 % |
| Q1 | 2024-05-02 | $-0.09 | $-0.33 | 72.7 % |
Castle Biosciences (CSTL) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-02-27 | $86.31M | $83.89M | 2.89 % |
| Q3 | 2024-11-04 | $85.78M | $79.84M | 7.44 % |
| Q2 | 2024-08-05 | $87.00M | $69.08M | 25.9 % |
| Q1 | 2024-05-02 | $72.97M | $66.20M | 10.2 % |
FAQ
When is Castle Biosciences (NASDAQ:CSTL) reporting earnings?
Castle Biosciences (CSTL) is scheduled to report earnings on August 4, 2025. The last reported earnings were for reported on May 5, 2025 for Q1.
What were the latest earnings per share (EPS) for Castle Biosciences (NASDAQ:CSTL)?
The Actual EPS was $0.00, which beat the estimate of $-0.07.
What were Castle Biosciences’s (NASDAQ:CSTL) revenues?
The Actual Revenue was $0K, which missed the estimate of $80.4M.
Browse earnings estimates, EPS, and revenue on all stocks.
